封面
市場調查報告書
商品編碼
1298660

藥物警戒和藥物安全軟體市場:2023-2028年全球行業趨勢、佔有率、規模、成長、機會及預測

Pharmacovigilance and Drug Safety Software Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

出版日期: | 出版商: IMARC | 英文 139 Pages | 商品交期: 2-3個工作天內

價格

全球藥物警戒和藥物安全軟體市場規模在2022年達到1.899億美元。展望未來,IMARC Group預計到2028年,該市場規模將達到2.833億美元,2023-2028年期間的年復合成長率(CAGR)為6.51%。

藥物警戒和藥品安全軟體用於檢測、評估、了解和預防與藥品、醫療器械和醫藥產品相關的不良反應。全球的醫療保健公司都在使用該軟體,以確保全球監管合規性,更快地做出科學的安全決策,整合安全和風險管理,並降低藥物警戒的成本。如今,服務提供商正在提供靈活、創新和可擴展的變體,以滿足醫療保健公司獨特的業務和產品安全要求。

藥物警戒和藥品安全軟體市場趨勢:

藥物警戒和藥物安全監測是醫藥產品開發商、許可證持有者和臨床研究者的強制性要求。然而,藥物警戒和藥物安全監測是一個時間密集、成本高昂的過程,這也是促使採用藥物警戒和藥物安全軟體來維護安全數據、降低成本並提供最佳監測和報告工作流程的關鍵因素之一。此外,許多國家的衛生機構正在實施嚴格的公共衛生法律,這也鼓勵製藥和生物技術公司採用高效的藥物警戒和藥物安全軟體。此外,由於藥物不良反應(ADR)發生率的上升,全球對安全藥物和藥品的需求也在不斷攀升,這也促進了市場的成長。除此之外,由於臨床試驗的快速數位化,藥物警戒和藥物安全軟體的採用率也在上升,以確保在不破壞傳統訊號檢測、驗證和管理工作流程的情況下實施新方法。此外,知名廠商正在實施自動化,採用先進技術,並利用分析結果提高藥物警戒和藥物安全軟體的合規性和產品安全性。預計這將為市場帶來積極的前景。

目錄

第一章:前言

第二章:範圍和方法

  • 研究目標
  • 利益相關者
  • 數據來源
    • 第一手資料
    • 二手資料
  • 市場評估
    • 自下而上法
    • 自上而下法
  • 預測方法

第三章:執行摘要

第四章: 簡介

  • 概述
  • 主要行業趨勢

第5章:全球藥物警戒和藥物安全軟體市場

  • 市場概述
  • 市場表現
  • COVID-19的影響
  • 市場預測

第六章:按功能分類的市場細分

  • 不良事件報告軟體
    • 市場趨勢
    • 市場預測
  • 藥品安全審計軟體
    • 市場趨勢
    • 市場預測
  • 問題追踪軟體
    • 市場趨勢
    • 市場預測
  • 全整合軟體
    • 市場趨勢
    • 市場預測

第七章:按交付模式分類的市場細分

  • 企業內部
    • 市場趨勢
    • 市場預測
  • 雲端運算
    • 市場趨勢
    • 市場預測

第八章:按最終用戶分類的市場細分

  • 製藥和生物技術公司
    • 市場趨勢
    • 市場預測
  • 契約研究組織
    • 市場趨勢
    • 市場預測
  • 業務流程外包公司
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第九章:按地區分類的市場細分

  • 北美洲
    • 美國
      • 市場趨勢
      • 市場預測
    • 加拿大
      • 市場趨勢
      • 市場預測
  • 亞太地區
    • 中國
      • 市場趨勢
      • 市場預測
    • 日本市場
      • 市場趨勢
      • 市場預測
    • 印度市場
      • 市場趨勢
      • 市場預測
    • 韓國
      • 市場趨勢
      • 市場預測
    • 澳大利亞
      • 市場趨勢
      • 市場預測
    • 印尼
      • 市場趨勢
      • 市場預測
    • 其他市場
      • 市場趨勢
      • 市場預測
  • 歐洲
    • 德國
      • 市場趨勢
      • 市場預測
    • 法國
      • 市場趨勢
      • 市場預測
    • 英國
      • 市場趨勢
      • 市場預測
    • 義大利市場
      • 市場趨勢
      • 市場預測
    • 西班牙
      • 市場趨勢
      • 市場預測
    • 俄羅斯
      • 市場趨勢
      • 市場預測
    • 其他市場
      • 市場趨勢
      • 市場預測
  • 拉丁美洲
    • 巴西市場
      • 市場趨勢
      • 市場預測
    • 墨西哥市場
      • 市場趨勢
      • 市場預測
    • 其他市場
      • 市場趨勢
      • 市場預測
  • 中東和非洲
    • 市場趨勢
    • 各國市場細分
    • 市場預測

第10章:SWOT分析

  • 概述
  • 優勢
  • 劣勢
  • 機會
  • 威脅

第十一章:價值鏈分析

第十二章:波特五力分析

  • 五力分析概述
  • 買方議價能力
  • 供應商議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第13章:價格分析

第十四章:競爭格局

  • 市場結構
  • 主要競爭者
  • 主要競爭者簡介
    • Ab Cube
    • Anju Software Inc.
    • ArisGlobal LLC
    • Cognizant
    • Ennov Solutions Inc.
    • Extedo GmbH
    • Max Application
    • Oracle Corporation
    • Sarjen Systems Pvt Ltd
    • Sparta Systems Inc. (Honeywell International Inc.)
    • Tata Consultancy Services Limited
    • United BioSource LLC
    • Wipro Limited
Product Code: SR112023A5030

The global pharmacovigilance and drug safety software market size reached US$ 189.9 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 283.3 Million by 2028, exhibiting a growth rate (CAGR) of 6.51% during 2023-2028.

Pharmacovigilance and drug safety software is used to detect, assess, understand, and prevent adverse effects related to medicines, medical devices, and pharmaceutical products. It is utilized by health firms worldwide to ensure global regulatory compliance, make faster science-based safety decisions, integrate safety and risk management, and lower the cost of pharmacovigilance. Nowadays, service providers are offering flexible, innovative, and scalable variants to meet the unique business and product safety requirements of health firms.

Pharmacovigilance and Drug Safety Software Market Trends:

Pharmacovigilance and drug safety monitoring are mandatory requirements for medicinal product developers, license holders, and clinical investigators. However, they can be time-intensive and costly processes, which represents one of the key factors catalyzing the adoption of pharmacovigilance and drug safety software to maintain safety data, minimize costs, and deliver best-practice monitoring and reporting workflows. In addition to this, health agencies of numerous countries are implementing stringent laws regarding public health, which is encouraging pharmaceutical and biotechnology companies to adopt efficient software for pharmacovigilance and drug safety. Moreover, the escalating demand for safe drugs and medicines around the world on account of the increasing incidences of adverse drug reaction (ADR) is contributing to the market growth. Apart from this, due to the rapid digitization of clinical trials, there is a rise in the adoption of pharmacovigilance and drug safety software to ensure the implementation of novel methods without disrupting traditional signal detection, validation, and management workflow. Furthermore, prominent vendors are implementing automation, adopting advanced technologies, and leveraging insights from analytics that improve compliance and product safety in pharmacovigilance and drug safety software. This is anticipated to provide a positive outlook for the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global pharmacovigilance and drug safety software market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on functionality, delivery mode and end user.

Breakup by Functionality:

Adverse Event Reporting Software

Drug Safety Audits Software

Issue Tracking Software

Fully Integrated Software

Breakup by Delivery Mode:

On-premises

Cloud-based

Breakup by End User:

Pharmaceutical and Biotechnology Companies

Contract Research Organizations

Business Process Outsourcing Firms

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Ab Cube, Anju Software Inc., ArisGlobal LLC, Cognizant, Ennov Solutions Inc., Extedo GmbH, Max Application, Oracle Corporation, Sarjen Systems Pvt Ltd, Sparta Systems Inc. (Honeywell International Inc.), Tata Consultancy Services Limited, United BioSource LLC and Wipro Limited.

Key Questions Answered in This Report

1. What was the size of the global pharmacovigilance and drug safety software market in 2022?

2. What is the expected growth rate of the global pharmacovigilance and drug safety software market during 2023-2028?

3. What has been the impact of COVID-19 on the global pharmacovigilance and drug safety software market?

4. What are the key factors driving the global pharmacovigilance and drug safety software market?

5. What is the breakup of the global pharmacovigilance and drug safety software market based on the functionality?

6. What is the breakup of the global pharmacovigilance and drug safety software market based on the delivery mode?

7. What is the breakup of the global pharmacovigilance and drug safety software market based on the end user?

8. What are the key regions in the global pharmacovigilance and drug safety software market?

9. Who are the key players/companies in the global pharmacovigilance and drug safety software market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Pharmacovigilance and Drug Safety Software Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Functionality

  • 6.1 Adverse Event Reporting Software
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Drug Safety Audits Software
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Issue Tracking Software
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Fully Integrated Software
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Delivery Mode

  • 7.1 On-premises
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Cloud-based
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Pharmaceutical and Biotechnology Companies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Contract Research Organizations
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Business Process Outsourcing Firms
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Ab Cube
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Anju Software Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 ArisGlobal LLC
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Cognizant
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Ennov Solutions Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Extedo GmbH
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Max Application
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Oracle Corporation
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Sarjen Systems Pvt Ltd
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Sparta Systems Inc. (Honeywell International Inc.)
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Tata Consultancy Services Limited
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 United BioSource LLC
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
    • 14.3.13 Wipro Limited
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 Financials
      • 14.3.13.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Pharmacovigilance and Drug Safety Software Market: Major Drivers and Challenges
  • Figure 2: Global: Pharmacovigilance and Drug Safety Software Market: Sales Value (in Million US$), 2017-2022
  • Figure 3: Global: Pharmacovigilance and Drug Safety Software Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 4: Global: Pharmacovigilance and Drug Safety Software Market: Breakup by Functionality (in %), 2022
  • Figure 5: Global: Pharmacovigilance and Drug Safety Software Market: Breakup by Delivery Mode (in %), 2022
  • Figure 6: Global: Pharmacovigilance and Drug Safety Software Market: Breakup by End User (in %), 2022
  • Figure 7: Global: Pharmacovigilance and Drug Safety Software Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Pharmacovigilance and Drug Safety Software (Adverse Event Reporting Software) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Pharmacovigilance and Drug Safety Software (Adverse Event Reporting Software) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Pharmacovigilance and Drug Safety Software (Drug Safety Audits Software) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Pharmacovigilance and Drug Safety Software (Drug Safety Audits Software) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Pharmacovigilance and Drug Safety Software (Issue Tracking Software) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Pharmacovigilance and Drug Safety Software (Issue Tracking Software) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Pharmacovigilance and Drug Safety Software (Fully Integrated Software) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Pharmacovigilance and Drug Safety Software (Fully Integrated Software) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Pharmacovigilance and Drug Safety Software (On-premises) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Pharmacovigilance and Drug Safety Software (On-premises) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Pharmacovigilance and Drug Safety Software (Cloud-based) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Pharmacovigilance and Drug Safety Software (Cloud-based) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Pharmacovigilance and Drug Safety Software (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Pharmacovigilance and Drug Safety Software (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Pharmacovigilance and Drug Safety Software (Contract Research Organizations) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Pharmacovigilance and Drug Safety Software (Contract Research Organizations) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Pharmacovigilance and Drug Safety Software (Business Process Outsourcing Firms) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Pharmacovigilance and Drug Safety Software (Business Process Outsourcing Firms) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Pharmacovigilance and Drug Safety Software (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Pharmacovigilance and Drug Safety Software (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: North America: Pharmacovigilance and Drug Safety Software Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: North America: Pharmacovigilance and Drug Safety Software Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: United States: Pharmacovigilance and Drug Safety Software Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: United States: Pharmacovigilance and Drug Safety Software Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Canada: Pharmacovigilance and Drug Safety Software Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Canada: Pharmacovigilance and Drug Safety Software Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Asia-Pacific: Pharmacovigilance and Drug Safety Software Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Asia-Pacific: Pharmacovigilance and Drug Safety Software Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: China: Pharmacovigilance and Drug Safety Software Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: China: Pharmacovigilance and Drug Safety Software Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: Japan: Pharmacovigilance and Drug Safety Software Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: Japan: Pharmacovigilance and Drug Safety Software Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: India: Pharmacovigilance and Drug Safety Software Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: India: Pharmacovigilance and Drug Safety Software Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: South Korea: Pharmacovigilance and Drug Safety Software Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: South Korea: Pharmacovigilance and Drug Safety Software Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Australia: Pharmacovigilance and Drug Safety Software Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Australia: Pharmacovigilance and Drug Safety Software Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Indonesia: Pharmacovigilance and Drug Safety Software Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Indonesia: Pharmacovigilance and Drug Safety Software Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Others: Pharmacovigilance and Drug Safety Software Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Others: Pharmacovigilance and Drug Safety Software Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Europe: Pharmacovigilance and Drug Safety Software Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Europe: Pharmacovigilance and Drug Safety Software Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Germany: Pharmacovigilance and Drug Safety Software Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Germany: Pharmacovigilance and Drug Safety Software Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: France: Pharmacovigilance and Drug Safety Software Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: France: Pharmacovigilance and Drug Safety Software Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: United Kingdom: Pharmacovigilance and Drug Safety Software Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: United Kingdom: Pharmacovigilance and Drug Safety Software Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Italy: Pharmacovigilance and Drug Safety Software Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Italy: Pharmacovigilance and Drug Safety Software Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Spain: Pharmacovigilance and Drug Safety Software Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Spain: Pharmacovigilance and Drug Safety Software Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Russia: Pharmacovigilance and Drug Safety Software Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Russia: Pharmacovigilance and Drug Safety Software Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Others: Pharmacovigilance and Drug Safety Software Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Others: Pharmacovigilance and Drug Safety Software Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Latin America: Pharmacovigilance and Drug Safety Software Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Latin America: Pharmacovigilance and Drug Safety Software Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Brazil: Pharmacovigilance and Drug Safety Software Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Brazil: Pharmacovigilance and Drug Safety Software Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Mexico: Pharmacovigilance and Drug Safety Software Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Mexico: Pharmacovigilance and Drug Safety Software Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Others: Pharmacovigilance and Drug Safety Software Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Others: Pharmacovigilance and Drug Safety Software Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Middle East and Africa: Pharmacovigilance and Drug Safety Software Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Middle East and Africa: Pharmacovigilance and Drug Safety Software Market: Breakup by Country (in %), 2022
  • Figure 76: Middle East and Africa: Pharmacovigilance and Drug Safety Software Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Global: Pharmacovigilance and Drug Safety Software Industry: SWOT Analysis
  • Figure 78: Global: Pharmacovigilance and Drug Safety Software Industry: Value Chain Analysis
  • Figure 79: Global: Pharmacovigilance and Drug Safety Software Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Pharmacovigilance and Drug Safety Software Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Pharmacovigilance and Drug Safety Software Market Forecast: Breakup by Functionality (in Million US$), 2023-2028
  • Table 3: Global: Pharmacovigilance and Drug Safety Software Market Forecast: Breakup by Delivery Mode (in Million US$), 2023-2028
  • Table 4: Global: Pharmacovigilance and Drug Safety Software Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 5: Global: Pharmacovigilance and Drug Safety Software Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Pharmacovigilance and Drug Safety Software Market: Competitive Structure
  • Table 7: Global: Pharmacovigilance and Drug Safety Software Market: Key Players